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ABSTRACT
The CCR4–NOT complex plays an important role in
the translational repression and deadenylation of
mRNAs. However, little is known about the specific
roles of interacting factors. We demonstrate that the
DEAD-box helicases eIF4A2 and DDX6 interact di-
rectly with the MA3 and MIF domains of CNOT1 and
compete for binding. Furthermore, we now show that
incorporation of eIF4A2 into the CCR4–NOT complex
inhibits CNOT7 deadenylation activity in contrast to
DDX6 which enhances CNOT7 activity. Polyadenyla-
tion tests (PAT) on endogenous mRNAs determined
that eIF4A2 bound mRNAs have longer poly(A) tails
than DDX6 bound mRNAs. Immunoprecipitation ex-
periments show that eIF4A2 does not inhibit CNOT7
association with the CCR4–NOT complex but instead
inhibits CNOT7 activity. We identified a CCR4–NOT
interacting factor, TAB182, that modulates helicase
recruitment into the CCR4–NOT complex, potentially
affecting the outcome for the targeted mRNA. To-
gether, these data show that the fate of an mRNA
is dependent on the specific recruitment of either
eIF4A2 or DDX6 to the CCR4–NOT complex which
results in different pathways for translational repres-
sion and mRNA deadenylation.
INTRODUCTION
The poly(A) tail at the 3′end of mRNAs plays a critical
role in the life-cycle of an mRNA. Most mRNAs receive
a poly(A) tail in the nucleus and regulation of the poly(A)
tail length of each mRNA is subject to strict regulation (1).
The poly(A) tail is bound by PABP, which acts both at the
level of translation as well as mRNA stability via altering
the poly(A) status of the mRNA (2–4). PABP also inter-
acts with the eIF4F complex which in turn interacts with
the cap structure at the 5′end of the mRNA resulting in
mRNAs forming a closed loop conformation, stimulating
translation efficiency. However, when an mRNA is targeted
for deadenylation and decay, PABP can also interact with
the CCR4–NOT complex which is critical for the removal
of the poly(A) tail (5,6).
The CCR4–NOT complex plays an important role in
many aspects of eukaryotic gene expression, but it is best
known for its role in the translational repression and dead-
enylation of mRNAs (7). The CCR4–NOT complex is re-
cruited to mRNAs in diverse ways, such as via miRNAs,
RNA modification and/or RNA-BPs (8–12). CCR4–NOT
recruitment results in translational repression, deadenyla-
tion and degradation of an mRNA (7). The CCR4–NOT
complex is a large multiprotein complex with several pro-
teins assembled around the scaffolding protein CNOT1.
Amongst these proteins are the deadenylases CNOT7/8
which in turn bind CNOT6/6L (13). These deadenylases
collaborate with each other and PABP to remove the
poly(A) tail of an mRNA (5,6). Other important subunits
are CNOT3, which plays a role in mRNA surveillance and
mRNA export from the nucleus, and CNOT9 which inter-
acts with TNRC6, one of the main effectors of the miRNA
pathway (14).
Recently, two DEAD-box helicases, eIF4A2 (15; unpub-
lished dataWilczynska et al.) and DDX6 (16–19) have been
identified and shown to play a critical role in miRNAmedi-
ated translational repression via the CCR4–NOT complex.
eIF4A2 is a paralogue of eIF4A1 and although the amino
acid sequences of both proteins are highly similar they have
opposing functions, resulting in contrasting effects of the
helicases in cancer (20). eIF4A1 levels are increased in sev-
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eral cancers and predict poor prognosis, whilst high eIF4A2
levels are linked to better survival rates (20). eIF4A1 and
eIF4A2 also have distinct functions in viral replication (21).
eIF4A1 binds to theMIF andMA3 domains of eIF4G and
is required for unwinding of the secondary structure in the
5′UTR of an mRNA while the initiation complex scans for
the start codon (22,23). Therefore, eIF4A1 plays an impor-
tant role in the translation efficiency of an mRNA. How-
ever, eIF4A2 interacts with the CCR4–NOT complex in-
stead and is critical for translational repression and desta-
bilization of the mRNAs it binds (15,24,25). DDX6 also in-
teracts with the CCR4–NOT complex and has been shown
to bind directly to CNOT1 (16–18).
So far there is no consensus regarding the exact func-
tion of the helicases interacting with the CCR4–NOT com-
plex. Different research groups have detected either a role
for eIF4A2 (15,26,27; unpublished data Wilczynska et al.)
orDDX6 inmiRNAmediated translational repression (16–
19). The exact role of eIF4A2 remains under discussion
with some research showing that eIF4A2 is required for
miRNAmediated repression (15) whilst other research sug-
gests that miRNA mediated repression results in the disso-
ciation of eIF4A (26,27). However, other research has sug-
gested that eIF4A2 is not required for miRNA mediated
repression (16,17,19,28). The use of different model sys-
tems and technical approaches complicates a direct com-
parison of these studies. Endogenous eIF4A2 binds pref-
erentially to CNOT1 (15,25). However, when eIF4A2 is
overexpressed it has a tendency to interact with eIF4GI
rather than CNOT1 (17,27,29; unpublished data Wilczyn-
ska et al.). When eIF4A2 is overexpressed at high levels
it becomes difficult to differentiate between eIF4A1 and
eIF4A2 which could result in inaccurate interpretation of
the interactions when obtained with overexpression ap-
proaches (unpublished data Wilczynska et al.). With the
data available so far we are currently not able to explain the
differences observed by the different research groups.
Here, we show that both DEAD-box helicases eIF4A2
and DDX6 as well as deadenylase CNOT7 are required
for translational repression via CNOT1. We have analysed
the domains of the central part of CNOT1 and determined
that the MA3 and MIF domains are essential for max-
imal helicase binding and function. Both helicases bind
CNOT1 directly and compete for binding.We identified an-
other CNOT1 binding protein, TAB182, which can affect
helicase selection into the CCR4–NOT complex. This has
immediate consequences for the fate of the mRNA as we
demonstrated that eIF4A2 and DDX6 have distinct and
opposing effects on the ability of CNOT7 to deadenylate
the targeted mRNA. eIF4A2 interferes with the ability of
CNOT7 to deadenylate an mRNA whilst DDX6 stimu-
lates CNOT7 activity. Consequentially, analysis of mRNAs
bound to eIF4A2 showed that these mRNAs had a much
longer poly(A) tail thanmRNAs bound toDDX6. The data
presented here shows that the poly(A) tail length ofmRNAs
bound by the CCR4–NOT complex is determined by the re-
cruitment of either eIF4A2 or DDX6 to the CCR4–NOT
complex and the subsequent impact on deadenylation.
MATERIALS AND METHODS
Constructs
pRLSV40 (pRL) and pGL3 were obtained from Promega.
pRLSV40 let-7 (eight let-7 repeats) has been described
previously (30). pGL3 intron was generated by insert-
ing a PCR product generated with pRLSV40 as template
and primers Intron-F1/R1 into the HindIII and NcoI
sites of pGL3. The tethering constructs (N)HA-CNOT1-
MA3-MIF-DUF, (N)HA-CNOT1-MA3-MIF and (N)HA-
CNOT1-MIF were generated by cloning PCR prod-
ucts (primers CNOT1-F1/F2/F3/R1/R2/R3 and tem-
plate NHA-CNOT1C into the EcoRI and NotI sites
of HA-CNOT1C and NHA-CNOT1C. The mutants
4G23 and CAF were generated using the same primers
with templates NHA-CNOT1Cmut4G2+4G3 and NHA-
CNOT1CmutCAF. The tethering controls (N)HA-GFP
were generated by cloning PCR products (primers GFP-
F1/R1) into the EcoRI and NotI sites of HA-CNOT1-
MIF andNHA-CNOT1-MIF. The tethering reporter Rluc-
BoxB-HsL-HhR, the plasmids used as templates and vec-
tors for the cloning were a gift from Witek Filipow-
icz (31,32). The coding sequence of CNOT7 was ampli-
fied using primers CNOT7-F/R and cloned into pET-45b.
PCRs were performed using KOD polymerase (Merck) ac-
cording to the manufacturer’s instructions. cDNAs corre-
sponding to eIF4A1 (primers TS3/TS4), eIF4A2 (primers
TS5/TS6), DDX6 (primers TS7/TS8), eIF4G-MIF-MA3
(primers TS9/TS10), CNOT1-MIF (primers TS21/TS22)
and CNOT1-MA3-MIF (primers TS19/TS22) were cloned
into pET-SUMO vector using the BsaI andNotI restriction
sites. eIF4A2DAAD has been generated by site-directed mu-
tagenesis using primers TS38/TS39. These PCRs were per-
formed using Phusion polymerase (Thermo Fisher Scien-
tific) according to manufacturer’s instructions. For primer
sequences see Supplementary Table S1.
Cell lines, siRNAs and transfections and reporter assays
Two cell lines were used in this paper: HeLa and HEK293.
Both were cultured inDMEMsupplemented with 10%FBS
and 2 mM L-glutamine. siRNAs (see Supplementary Ta-
ble S2) were transfected on day 1 using 1 l/ml (HeLa)
or 2 l/ml (HEK293 and Figure 5D, Supplementary Fig-
ure S7G) DharmafectI (Dharmacon). siRNA concentra-
tion varied between experiments: 30 nM (Figure 5C, Sup-
plementary Figure S9), 2 × 30 nM (Figure 1A, C, Sup-
plementary Figures S2A–B, S2E–G), 60 nM (Figures 2B,
4 and 8C, Supplementary Figures S3, S5 and S6), 2 × 60
nM (Figures 1F, 3, Supplementary Figure S2C–D), 120 nM
(Figure 5D, Supplementary Figure S7G). Cells were trans-
fected with plasmids on day 2 using 1l/ml (, Supplemen-
tary Figure S5D: 2 ul/ml) Genejammer (Agilent). For let-
7 reporter assays 40 ng/ml pRL/pRL-let-7 and 160 ng/ml
pGL3-intron were used. For tethering assays 300 ng/ml
(N)HA overexpression plasmid, 50 ng/ml BoxB reporter
and 200 ng/ml pGL3-intron were used. For the tethering of
(N)HA-GFP 0.3 ng/ml was used to obtain similar expres-
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Figure 1. eIF4A2 and DDX6 are both required for CNOT1 mediated
translational repression. (A) HeLa cells were transfected with siRNAs as
indicated. Cells were lysed in RIPA buffer after 72 h. Lysates were anal-
ysed using western blotting. Representative blots are shown. GAPDH is a
loading control. *Indicates a nonspecific band. (B) Schematic representa-
tion of constructs used in the let-7 reporter assay. (C) HEK293 cells were
transfected with siRNAs and after 24 h with the plasmids from (B) as in-
dicated. Cells were lysed in PLB after a further 24 h and analysed by lu-
ciferase assay. Luciferase activity was plotted as average ± sd, n = 4 bio-
logical repeats. Significance was calculated using a Student’s t-test (paired,
two-tailed); **P< 0.01, ***P< 0.001. (D) Schematic representation of the
CNOT1 domains. (E) Schematic representation of the constructs used in
the tethering assay. N-tag was required for tethering, HA tag was used for
western blotting. (F) HeLa cells were transfectedwith siRNAs andwith the
plasmids from (E) after 24 h as indicated. Cells were lysed in PLB after a
further 48 h and analysed by luciferase assay. Luciferase activity was plot-
ted as average ± sd, n = 3 biological repeats. Significance was calculated
using a Student’s t-test (paired, two-tailed); *P < 0.05, **P < 0.01.
sion levels to (N)HA-CNOT1. pGL3-intron was used as a
transfection control for all reporter assays. For overexpres-
sion of HA tagged proteins 1 g/ml HA plasmid was used.
Cells were harvested on day 3 (let-7 reporter, overexpression
immunoprecipitations) or day 4 (endogenous targets, teth-
ering) and lysed in 1× PLB, Trizol, RIPA or IP buffer. PLB
and Trizol samples were immediately frozen at −80◦C. Lu-
ciferase assays were performed as described previously (15).
Protein concentrations were determined using Biorad Pro-
tein Assay.
RNA, RT and qPCR
RNA from transfected cells, cleared lysate or gel filtration
fractions was isolated using 1 ml of Trizol (Invitrogen) ac-
cording to the manufacturer’s protocol. RNA yield and pu-
rity (A260/280) was determined using a nanodrop 2000
(Thermo Scientific). Reverse transcription of 500 ng of to-
tal RNA was performed using random hexamers and Su-
perscriptIII (Invitrogen) following the manufacturer’s in-
structions. qPCR was performed on a 7500 Fast Real Time
PCR System (Applied Biosystems) using Fast Sybr Green
Mastermix (Applied Biosystems) according to the manu-
facturer’s protocol and analysed using 7500 software v2.3
(Applied Biosystems). Cycling conditions were as follows:
denaturation for 20 s at 95◦C followed by 40 cycles of 3 s
at 95◦C and 30 s at 60◦C. For each biological repeat, three
technical repeats were performed. For primers used see Sup-
plementary Table S1. Renilla and Firefly plasmids used in
the transfections contained an intron and primers were in-
tron spanning. No RT and no template controls were in-
cluded. The Renilla amplicon length was 106 bp (let-7 re-
porters) or 109 bp (tethering reporters) and the Firefly am-
plicon length was 107 bp. Renilla mRNA levels were nor-
malized for Firefly mRNA levels. Meltcurves were deter-
mined for each experiment. Standard curves were obtained
for each primer pair. Coefficients of determination were
0.9865–0.9996. PCR efficiencies were 97–108%. Tresholds
were automatically determined by the 7500 software based
on the signal obtained during cycles 3–15. Observed Ct val-
ues for experimental samples were on average 12 Ct values
lower than no template controls.
Gel filtration columns
Cytoplasmic HeLa lysates (Ipracell) were cleared by cen-
trifugation for 15min at 13 000 rpm at 4◦C and fractionated
by size-exclusion chromatography using a HiPrep 16/60
Sephacryl S-500 HR column connected to an AKTApu-
rifier protein purification system (GE Healthcare Life Sci-
ences). The column was eluted at 4◦C with 5% (w/v) su-
crose, 0.1% (w/v) CHAPS, 20 mM HEPES–NaOH, 5 mM
DTT and 150 mM NaCl, pH 7.0, at 0.15 ml/min and 2 ml
fractions collected.
Recombinant protein purification
eIF4A1, eIF4A2, DDX6, eIF4G-MIF-MA3, CNOT1-
MA3-MIF and CNOT1-MIF were heterologously pro-
duced in Escherichia coli BL21 (DE3) CodonPlus-RP as N-
terminal 6xHis-SUMO-fusion proteins. CNOT7 was pro-
duced as N-terminal 6xHIS-tagged protein. Biomass was
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Figure 2. eIF4A2 and DDX6 both interact directly with CNOT1 and compete for binding. (A) Immunoprecipitation from untransfected HeLa lysates
with CNOT1 antibody or IgG as indicated. Protein complexes were eluted from the beads using a CNOT1 peptide and analysed by western blotting.
Representative blots are shown. (B) HeLa cells were transfected with siRNA and analysed by proximity ligation assay (PLA) as in Supplementary Figure
S3A–B. PLA dots were counted using ImageJ and plotted as average number of PLA dots per cell± sd, n= 3 biological repeats. Significance was calculated
using a Student’s t-test (paired, two-tailed); *P < 0.05, **P < 0.01, ***P < 0.001. (C) Recombinant eIF4A2 and DDX6 proteins were incubated with
recombinant CNOT1-MA3-MIF and subsequently pulled down with the indicated antibodies and analysed by denaturing SDS-PAGE and Coomassie-
staining. A representative gel is shown. (D) Recombinant proteins were mixed at increasing concentrations of eIF4A2 and assembled complexes were pulled
down via the HIS-tag of CNOT1. Co-precipitated proteins were analysed by SDS-PAGE and Coomassie-staining. A representative gel is shown.
Figure 3. The MIF domain of CNOT1 is sufficient for maximum repression but both the MA3 and MIF domains are required for maximum helicase
response and maximum helicase binding. (A) Schematic representation of constructs used in the tethering assay. (B) HeLa cells were transfected and
analysed as in Figure 1F with the constructs depicted in (A) and analysed by luciferase assay, n = 4 biological repeats. Significance was calculated using a
Student’s t-test (paired, two-tailed); **P < 0.01, ***P < 0.001, n.s. = not significant.
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produced applying standard protocols for IPTG-induction.
Cells were harvested, resuspended and lysed in buffer A
(20 mM Tris–HCl, pH 7.5, 1 M NaCl, 30 mM imidazole,
10% (v/v) glycerol) supplemented with 1 mM PMSF and
complete EDTA-free protease inhibitor cocktail (Roche).
After centrifugation at 75 000 g supernatant was filtered
(5 m) and applied to HisTrap (GE Healthcare) affin-
ity chromatography. Bound protein was eluted with a lin-
ear imidazole gradient. Pooled fractions were diluted in
buffer B (20 mM Tris–HCl, pH 7.5, 10% (v/v) glycerol,
0.1 mM EDTA) and except from CNOT7 pools incubated
with SUMO-protease for 1 h at 8◦C for cleavage of the
SUMO-tag. CNOT7 proteins were incubated with TEV in-
stead. The protein solutions were further dilutedwith buffer
B and eIF4A1, eIF4A2, eIF4A2DAAD and CNOT1-MA3-
MIF were applied to a ResourceQ (GE Healthcare) an-
ion exchange and DDX6 and eIF4G-MIF-MA3 samples
to Heparin affinity chromatography. Bound protein was
eluted with a linear KCl gradient. Pooled fractions were
further purified by size exclusion chromatography using
a Superdex 200 column equilibrated in storage buffer (20
mMHEPES–KOH, pH 7.5, 100 mMKCl, 0.1 mM EDTA,
10% (v/v) glycerol, 1 mM Tris(2-carboxyethyl)phosphine).
In case of eIF4G-MIF-MA3 and CNOT1-MA3-MIF the
storage buffer contained 250 mM or 200 mM KCl respec-
tively. Pooled fractions were concentrated, snap-frozen in
liquid nitrogen and stored at−80◦C. Protein concentrations
were calculated from the absorbance at 280 nm (A280) using
extinction coefficients 34 630 M−1 cm−1 (eIF4A1), 40 130
M−1 cm−1 (eIF4A2), 30 745 M−1 cm−1 (DDX6), 69 495
M−1 cm−1 (eIF4G-MIF-MA3), 23 950M−1 cm−1 (CNOT1-
MIF), 41 830 M−1 cm−1 (CNOT1-MA3-MIF) and 39 225
M−1 cm−1 (CNOT7) obtained fromExPASy server. All pro-
tein preparations showed anA280/A260 ratio of≥1.9 indicat-
ing negligible amounts of contaminations by nucleic acids
and nucleotides.
Immunoprecipitations with recombinant proteins
To study CNOT1 interactions 3MCNOT1-MA3-MIF or
CNOT1-MIFwas incubated with 3Mof eIF4A1, eIF4A2
and DDX6 for 1 h at room temperature in NP-buffer (20
mMHEPES/KOH, pH 7.5, 100 mMKCl, 1 mMMgCl2, 2
mM DTT, 0.1% (v/v) NP40). In CNOT1 competition ex-
periments, reactions were performed in the presence of 5
M ssRNA (AG)10 (IBA life science) and 1 mMAMPPNP
(Sigma). For eIF4G interactions, 3 M eIF4G was incu-
bated with 3 M of eIF4A1, eIF4A2 and DDX6 for 1 h
at room temperature in NP-buffer. Per reaction 50 l Dyn-
abeads Protein G (Thermo Fisher Scientific) were washed
twice with NP-buffer and coated with 5 g of antibody (see
Supplementary Table S3) for 10 min in NP-buffer at room
temperature. Coated beads were washed 3× in NP-buffer
and incubated with protein samples for 15min at room tem-
perature. Beadswerewashed 3×withNP-buffer,mixedwith
SDS gel loading buffer, heated at 95◦C for 5 min and ap-
plied to denaturing polyacrylamide gel electrophoresis. Af-
ter electrophoresis, gels were stained with Coomassie and
bands visualized using a Licor Odyssey scanner.
Immunoprecipitations with cell lysates and gel filtration frac-
tions
HeLa or HEK293 cells were scraped in cold PBS and pel-
leted by centrifugation for 5 min at 4000 rpm at 4◦C. Pel-
lets were resuspended in IP buffer (5% (w/v) sucrose, 0.1%
(w/v) CHAPS, 20 mM HEPES, 50 mM NaCl, pH 7.0)
supplemented with 1× complete EDTA-free protease in-
hibitor cocktail (Roche) and 0.1% (v/v) ß-mercaptoethanol.
Lysates where treated with 50 U/ml benzonase in the pres-
ence of 10 mM MgCl2 by rotation for 1 h at 4◦C (Fig-
ure 5D only) or sonicated for 5 min followed by 10 min
on ice. Lysates were cleared by centrifugation for 15 min
at 4◦C at 13 000 rpm and supernatants used in subse-
quent steps. When commercial cytoplasmic HeLa lysate
(Ipracell) or gel filtration fractions were used the IP buffer
was supplemented with 5 mMDTT instead and benzonase
treatment/sonication was omitted. If the cells were treated
with siRNA 200 g protein was used per IP, for non-treated
cells equal volumes of lysate were used. For immunoprecip-
itations on gel filtration fractions 0.4 ml of fractions 30–32
were used and total volumes were increased to 2.6 ml per
sample. Per IP 25 l Dynabeads protein G beads (Thermo
Fisher Scientific) were incubated with 500 l lysate in IP
buffer for 1 h rotating at 4◦C. Another 25 l beads were
blocked by incubating in 1% BSA and 0.1 mg/ml tRNA in
IP buffer for 2 h rotating at 4◦C.The pre-cleared lysates were
transferred to new tubes and rotated in the presence of 10
g antibody (see Supplementary Table S3) for 1 h at 4◦C.
A volume equivalent to 25 l blocked beads was added to
the lysate/antibody mix and rotated for a further 2 h. The
beads were washed with 600 l IP buffer for 3× 10 min and
resuspended in SDS sample buffer. For some CNOT1 im-
munoprecipitations the protein complexes were eluted from
the beads in 12 g CNOT1 peptide (ProteinTech) in 60 l
0.6× IP buffer for 30min at 1600 rpm at 4◦C. The eluate was
thenmixed with SDS sample buffer. For the immunoprecip-
itation of HA-tagged overexpressed proteins the same pro-
tocol was used with the substitution of HA beads (Pierce)
for the Dynabeads and the protein complex was eluted us-
ing 120 g HA-peptide (Thermo Fisher Scientific) in 60 l
0.8× IP buffer for 10 min at 1600 rpm at 37◦C.
RNA immunoprecipitations
Per sample 8 × 106 HEK293 cells were lysed in lysis
buffer (20 mM Tris pH 7.5, 200 mM NaCl, 5 mM MgCl2,
0.5% (v/v) Triton-X100, 1× complete EDTA-free pro-
tease inhibitor cocktail (Roche), 1% BSA, 0.5 mM DTT, 5
mMNaF, 40 U/ml Riboblock (Thermo Fisher Scientific)).
Lysates were cleared by centrifugation for 10 min at 4◦C at
5000 rpm and supernatants used in subsequent steps. Six
microgram of antibody (see Supplementary Table S3) were
bound to 18 l of Dynabeads protein G beads (Thermo
Fisher Scientific) by rotating at 4◦C for 2.5 h and subse-
quently the beads were washed three times with lysis buffer.
Lysates were added and rotated for 30 min at 4◦C. Beads
were washed three times with lysis buffer and RNA was
extracted with Trizol reagent (Invitrogen) followed by acid
phenol extraction and ethanol precipitation.
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Proximity Ligation Assay (PLA)
siRNA treated HeLa cells were fixed for 10 min in 4%
paraformaldehyde at 4◦C. PLA was performed using the
Duolink In Situ reagents (Sigma) according to the man-
ufacturer’s protocol with additional washes in PBS after
fixing/blocking and additional washes in wash buffer A af-
ter primary antibody incubations. Blocking was done for 45
min at 37◦C in blocking solution with 0.3% (v/v) Triton.
Primary antibody incubations were performed for 1 h at
room temperature. For antibody dilutions see Supplemen-
tary Table S3. The images were acquired on a Zeiss LSM
510 META inverted confocal microscope equipped with a
multiphoton MaiTai, 488, 514, 543 and 633 nm laser lines
using a 63×/1.4 oil Plan-Apochromat objective. At least
100 cells were counted per condition per experiment. Im-
ageJ was used to count the number of PLA dots per cell.
Mass spectrometry
LC–MS/MS was performed as described previously (33).
Results were analysed in Scaffold (protein threshold 95%,
minimum two peptides). Proteins with spectra counts in
IgG or less than four spectra in either IP were removed.
For the CNOT1 immunoprecipitation experiments, all pep-
tides that were allocated to eIF4A1 also completely match
the eIF4A2 sequence and therefore could have been derived
from either protein. Although the MS did not enable us to
differentiate between eIF4A1 and eIF4A2 due to the high
similarity of these paralogues, since we used gel filtration
fractions 30–32 which contain very little eIF4A1 these pep-
tides have been allocated to eIF4A2.
Electrophoretic mobility shift RNA-binding
25 nM Dy680- labelled (CAA)6CA RNA (IBA life science)
was incubated with indicated proteins in binding buffer (20
mMHEPES/KOH, pH 7.5, 100 KCl, 1 mMMgCl2, 1 mM
AMP-PNP, 1 mM TCEP, 0.1% DMSO) in 10 l reactions
for 60min at 25◦C.Afinal concentration of 2% (w/v) Ficoll-
400 was added to the samples and complexes separated on
7% acrylamide-TB gels. Gels were scanned with Odyssey
(Licor).
Deadenylation assay
Recombinant proteins were incubated at room temper-
ature at 3 M in assay buffer (20 mM HEPES–KOH,
pH 7.5, 100 mM KCl, 1 mM MgCl2, 2 mM DTT) in
the presence of 1 mM AMPPNP (Sigma) and 1 M
fluorphor-labelled deadenylation substrate ssRNA Dy780-
(CAA)6CA-C20-A20 (IBA life science). For competition ex-
periments, 3 M DDX6, 3 M CNOT1 and indicated
concentrations of eIF4A2 were preincubated with RNA
and AMPPNP in assay buffer. After 1 h pre-incubation
an aliquot was taken and mixed 1:1 with stop solution
(0.5× TBE, 10 mMEDTA, 0.2% (w/v) SDS, 85% (v/v) for-
mamide) and Dy680-(CAA)6CA-C20 marker ssRNA. Re-
actions were then started by the addition of the CNOT7
nuclease at a final concentration of 0.5 M. At indicated
time points aliquots were taken and mixed 1:1 with stop so-
lution. Samples were heated for 2 min at 95◦C and loaded
on acrylamide–8M–urea TBE gels. After electrophoresis
gels were incubated for 5 min in 10% (v/v) acetic acid and
bands visualized using a Licor Odyssey scanner. Signals
were quantified using Image Studio software (Licor) and
the fraction of fully deadenylated product was plotted ver-
sus time using Prism GraphPad.
Polyadenylation test (PAT)
Total RNA was deadenylated by incubating 10 g RNA
in RNase H buffer (75 mM KCl, 50 mM Tris–HCl pH
8.3, 3 mM MgCl2, 10 mM DTT) supplemented with 8 g
oligo(dT) and 10U of RNaseH (NEB) in a total volume
of 100 l for 1 h at 37◦C. Deadenylated RNA was puri-
fied by phenol extraction and ethanol precipitation. RNA
used for the PAT was deadenylated RNA, total RNA or
RNA derived from RNA immunoprecipitation. The PAT
anchor oligo was ligated onto the RNA by adding 200 ng
RNA to the ligation mix (50 mM Tris–HCl pH 7.5, 10 mM
MgCl2, 1 mM DTT, 10% (w/v) PEG8000, 1 M PAT an-
chor oligo and 100 U of T4 RNA ligase 2––truncated KG
(NEB) in a total volume of 10 l) and incubated at 16◦C
overnight. Subsequently, the RNA was reverse transcribed
in First Strand Buffer (50 mM Tris–HCl pH 8.3, 75 mM
KCl, 3 mM MgCl2) supplemented with 5 mM DTT, 0.2
mM dNTPs, 1 M PAT-R1 oligo and 200 U Superscrip-
tIII (Invitrogen) in a total volume of 50 l. First the oligo
and dNTPs were added and the RNA was denatured for 5
min at 65◦C and cooled on ice. Then the remaining compo-
nents were added and the mixture incubated for 1 h at 55◦C,
followed by 15min at 70◦C. For the RNA IP samples qPCR
analysis was performed to determine relative amounts of
the targeted mRNAs (for primers, see Supplementary Ta-
ble S1). PCR products were then generated by two rounds
of PCR. cDNAwas amplified usingGoTaq (Roche) accord-
ing to the manufacturer’s protocol, using 1 l of cDNA
(the RNA IP samples were diluted using the PCR results
as guidance), PAT-R0 and gene-specific primer-PAT1 (see
Supplementary Table S1) in the first round. One microliter
of the resulting product was then amplified in a second
round using PAT-R1 and gene-specific primer-PAT2 (see
Supplementary Table S1). PCR program for both rounds: 5
min 95◦C (hotstart), 40 cycles consisting of 1 min at 95◦C, 1
min at 58◦C and 2 min at 72◦C, followed by 10 min at 72◦C.
The resulting PCR products were analysed on 4% high res-
olution agarose in TBE buffer (Sigma) containing SybrSafe
(1:10 000) and stained post run with SybrGold (1:10 000
in TBE) if required. Gels were imaged using a GeneFlash
Imager (Syngene).
Determination of antibody affinity and protein concentration
in lysate
To compare the affinities of the antibodies to their tar-
gets, specific amounts of the appropriate recombinant pro-
tein were separated on SDS-PAGE, transferred to the same
membrane and detected using their specific antibodies and
identical solution of secondary antibody. Band intensities
were quantified with Licor software (ImageStudio) and
plotted versus the protein amounts. The data were fit to a
straight line and the slopes of the fits were compared be-
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tween the individual antibodies to reveal their relative affin-
ity. To determine the relative protein amount of eIF4A1 and
eIF4A2 in HeLa lysate, different amounts of HeLa lysate
were analysed the same way side-by-side with a reference
titration of recombinant protein. The slopes of the fits were
compared between reference protein and Hela lysate to de-
termine the amount of eIF4A1 or eIF4A2 in the lysate.
Statistical analysis
For reporter assays, PLA and quantification of protein lev-
els three or four biological repeats (as indicated in the Fig-
ure legend for each experiment) were analysed using a Stu-
dent’s t-test (paired, two-tailed). Significance is indicated as
follows: *P < 0.05, **P < 0.01, ***P < 0.001, n.s. = not
significant.
RESULTS AND DISCUSSION
DEAD-box helicases eIF4A2 and DDX6 are both required
for translational repression via the CCR4–NOT complex
To determine the importance of eIF4A2 and DDX6 for
CCR4–NOT mediated translational repression we used
three different strategies in two different cell lines (Figure
1, Supplementary Figures S1 and S2). Firstly, we knocked
down both helicases individually or combined and showed
the impact on protein levels of endogenous miRNA tar-
gets. Protein levels of Imp1 and HMGA2 were increased
to varying degrees dependent on the helicase/target com-
bination but were always elevated when both helicases were
knocked down (Figure 1A). Secondly, we knocked down the
helicases in combination with transfection of a luciferase
reporter construct with or without let-7 target sites in the
3′UTR (Figure 1B). The presence of themiRNA target sites
clearly repressed luciferase activity and this was partially
reversed by knockdown of the individual helicases. Trans-
lation was completely restored after knockdown of both
helicases together or knockdown of the positive control
TNRC6A/B, which is required for the recruitment of the
CCR4–NOT complex bymiRNAs (Figure 1C; 34). Thirdly,
we combined the helicase knockdowns with a tethering re-
porter. Tethering of the central region of CNOT1 (MA3-
MIF-DUF; Figure 1D) has been shown to be sufficient for
translational repression (Supplementary Figure S1; 16). We
used a stabilized reporter which contains histone and ri-
bozyme hairpins in the 3′UTR for stabilization of the re-
porter mRNA substituting for a poly(A) tail (Figure 1E).
The reporter also contains BoxB hairpins in the 3′UTR for
tethering of CNOT1. To study the effect of eIF4A2 and
DDX6 on this reporter, we knocked down the helicases fol-
lowed by tethering of the central region of CNOT1 to the
stabilized reporter (Figure 1F). Again, both helicases were
required for translational repression. Knockdowns were ef-
ficient and changes ofmRNA levels were not responsible for
the observed effects on protein levels (Supplementary Fig-
ure S2A–D). To exclude the possibility that these effects are
siRNA specific we used alternative siRNAs for eIF4A2 and
DDX6 and repeated the let-7 reporter experiment (Supple-
mentary Figure S2E-G). The results were consistent, there-
fore the impact of the helicase knockdowns was not specific
to the particular siRNAs used for eIF4A2 or DDX6 knock-
downs. Taken together, these experiments showed that al-
though individual contributions of eIF4A2 and DDX6 are
context dependent, both are critical for translational repres-
sion via the CCR4–NOT complex.
eIF4A2 and DDX6 interact directly with CNOT1 and com-
pete for binding
Although it has been shown that both eIF4A2 (15,24) and
DDX6 (16–18) can interact with the CCR4–NOT com-
plex, how eIF4A2 interacts with the CCR4–NOT complex
is unclear. Previous research has demonstrated the ability
of the CNOT1 MIF domain to interact with the helicase
DDX6 and the deadenylase CNOT7, albeit on opposing
sides of the domain (16–18,35). The CNOT1 MIF domain
has a similar structure to the MIF domain of eIF4G which
is involved in eIF4A1 binding. To investigate the interac-
tion between the CCR4–NOT complex and the DEAD-box
helicases eIF4A1, eIF4A2 and DDX6 we performed en-
dogenous CNOT1 immunoprecipitation experiments (Fig-
ure 2A). Both DDX6 and eIF4A2 interacted with CNOT1,
but for eIF4A1 only a slight interaction was detected. The
eIF4A1 and eIF4A2 antibodies have almost identical affini-
ties for the proteins they are detecting (eIF4A1/eIF4A2
= 1.0; Supplementary Figure S3A). These results are in
agreement with previously published data (15,25). We then
employed proximity ligation assays (PLA) and confirmed
that both eIF4A2 and DDX6 were in very close proxim-
ity of CNOT1 in the cell, suggesting a direct interaction
(Figure 2B, Supplementary Figure S3B-D). Knockdown of
one of the interacting proteins or omitting one of the pri-
mary antibodies significantly reduced the number of PLA
dots (Figure 2B). The direct interaction was confirmed by
immunoprecipitations using recombinant proteins (Figure
2C) which showed that both eIF4A2 and DDX6 interact
directly with the central region of CNOT1. For this ex-
periment we used the MA3 and MIF domains of CNOT1
which proved to be sufficient for binding to both helicases.
To investigate in more detail the ability of the helicases to
bind CNOT1, we performed in vitro competition assays and
showed that eIF4A2 and DDX6 compete directly for bind-
ing to CNOT1 (Figure 2D). Previous research has only de-
tected the interaction between CNOT1 and DDX6 (16,17),
potentially because of the use of overexpression constructs
rather than endogenous proteins in immunoprecipitation
experiments.
To further define which domains of CNOT1 are reliant
on the helicases for function we tethered different CNOT1
domains to the BoxB reporter construct, focusing on the
region around the MIF domain (Figure 3A). The results
showed that although the MIF domain alone is sufficient
for maximum repression, both the MA3 and MIF domains
were required for maximum response to the helicase knock-
down, suggesting that both domains were required for op-
timal binding (Figure 3B, Supplementary Figure S4A-B).
We used immunoprecipitations using recombinant protein
to compare the interactions of the CNOT1 domains with
eIF4A2 and DDX6. Both helicases bind with similar effi-
ciency to CNOT1-MA3-MIF (Figure 2C). However, when
repeating the same experiment with only the MIF domain
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Figure 4. eIF4A2, DDX6 and CNOT7 are required for maximum repression via CNOT1. (A) HeLa cells were transfected and analysed as in Figure
1F with the constructs depicted in Figure 3A (right hand panel) and analysed by luciferase assay, n = 3 biological repeats. The CNOT1-MIFmut4G23
construct contains mutations that prevent helicase binding. (B) HeLa cells were transfected and analysed as in Figure 1F with the constructs depicted
in Figure 3A (right hand panel) and analysed by luciferase assay, n = 3 biological repeats. The CNOT1-MIFmutCAF construct contains mutations that
prevent CNOT7 binding. Significance was calculated using a Student’s t-test (paired, two-tailed); *P < 0.05, **P < 0.01, n.s. = not significant.
we could not detect an interaction with either helicase (Sup-
plementary Figure S4C). Previous research has observed an
interaction between CNOT1-MIF and DDX6 (16–18), but
this interaction was too weak to be detected under the con-
ditions we used. However, these experiments clearly show
that the MA3 and MIF domains were required for maxi-
mum binding to both eIF4A2 and DDX6 (Figure 2C, Sup-
plementary Figure S4C).
eIF4A2, DDX6 and CNOT7 are required and sufficient for
translational repression
To confirm the requirement of both helicases for transla-
tional repression, we inhibited the interaction of the he-
licases with CNOT1 in two different ways: we compared
the effect of the knockdown of the helicases on the tether-
ing of the wildtype CNOT1-MIF domain with a CNOT1-
MIFmutant domain that cannot interact with the helicases
(CNOT1-MIFmut4G23; Supplementary Figure S5A; 16).
The helicase binding mutant was not responsive to heli-
case depletion (Figure 4A, Supplementary Figure S5A–C),
confirming that this mutant does not interact with the he-
licases and that this interaction is required for the helicases
to function. To investigate why the MIF domain is resisting
full derepression when eIF4A2 and DDX6 were knocked
down we analysed a CNOT1 mutant that cannot bind the
deadenylase CNOT7 (CNOT1-MIFmutCAF; Supplemen-
tary Figure S5D; 16). When combining the helicase knock-
down with the CNOT7 binding mutant full translational
activity was restored, demonstrating that eIF4A2, DDX6
and CNOT7 are required and sufficient for translational re-
pression via the CNOT1-MIF domain (Figure 4B, Supple-
mentary Figure S5D–F). To establish the individual contri-
butions of each helicase to translational repression via the
MIF domain, we knocked down the helicases followed by
tethering of CNOT1-MIF (Supplementary Figure S6). The
derepression after the individual knockdown of either heli-
case was limited, but knock down of both helicases together
clearly increased translation levels of the tethering reporter.
Combined, these results demonstrated that eIF4A2, DDX6
and CNOT7 together play a critical role in translational re-
pression via the CCR4–NOT complex.
TAB182 affects helicase incorporation into the CCR4–NOT
complex
To further investigate CCR4–NOT complex composition
we separated protein complexes from cytoplasmic HeLa
lysate on a Sephacryl S-500 gel filtration column and anal-
ysed the resulting fractions by western blotting (Figure 5A,
Supplementary Figure S7A and B). These showed clearly
that the DEAD-box helicases eIF4A1, eIF4A2 and DDX6
have distinct migration patterns demonstrating that the he-
licases reside in separatemulti-protein complexes. A portion
of eIF4A2 and DDX6 proteins co-migrated with CNOT1
(fractions 30–32) whilst hardly any eIF4A1 was present in
the same fractions as CNOT1 (Figure 5A). Quantification
of eIF4A1 and eIF4A2 protein levels in fractions 30–32 as
well as in unfractionated HeLa lysate allowed us to calcu-
late the ratio of the eIF4A paralogues in the fractions. HeLa
lysate contains 0.7 ng eIF4A1 and 0.04 ng eIF4A2 per g
lysate (Supplementary Figure S7C). In gel filtration frac-
tions 30–32 the enrichment of eIF4A2 is 136× higher than
eIF4A1 (Supplementary Figure S7D).Together these re-
sults show that fractions 30–32 contain approximately eight
times more eIF4A2 than eIF4A1. Co-migration of CNOT1
and eIF4A2 is compatible but not proof that these proteins
are part of the same complex in these fractions. Therefore,
we confirmed the interaction of CNOT1 and eIF4A2 by
CNOT1 immunoprecipitation from fractions 30–32 in the
presence of RNaseA (Supplementary Figure S7E and F)
showing that CNOT1 and eIF4A2 were indeed forming a
complex. Performing the immunoprecipitation on lysate of
cells treated with CNOT1 siRNA resulted in the loss of the
complex showing the specificity of the interactions (Supple-
mentary Figure S7G).
To identify any other proteins that are part of the
eIF4A2–CNOT1 complex we separated protein complexes
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Figure 5. TAB182 affects eIF4A2 incorporation into the CCR4–NOT complex. (A) Gel filtration fractions 18–41 (from Supplementary Figure S7A) were
analysed by western blotting to allow for detailed analysis of migration patterns. Representative blots are shown. (B) Immunoprecipitation from HeLa
lysates with TAB182 antibody or IgG in the presence of RNaseA. Immunoprecipitates were analysed using western blotting. Representative blots are
shown. (C) HEK293 cells were transfected and analysed as in Figure 1C, n = 4 biological repeats. Significance was calculated using a Student’s t-test
(paired, two-tailed); *P < 0.05, **P < 0.01, ***P < 0.001. (D) HeLa cells were transfected with siRNAs as indicated. Cells were lysed after 72 h and
immunoprecipitated with the indicated antibodies. Protein complexes were eluted with CNOT1 peptide and analysed by western blotting. Representative
blots are shown. GAPDH is a loading control. (E) Quantification of three biological repeats of the experiment shown in Figure 5D. Significance was
calculated using a Student’s t-test (paired, two-tailed); *P < 0.05, n.s. = not significant.
from cytoplasmic HeLa lysate on a Sephacryl S-500 gel
filtration column followed by immunoprecipitations for
CNOT1 and eIF4A2 from fractions 30–32 (Supplementary
Figure S7H). The resulting samples were analysed by MS
which resulted in 107 potential CNOT1–eIF4A2 complex
binding proteins that were detected in both CNOT1 and
eIF4A2 immunoprecipitations but did not show any back-
ground binding to IgG (Supplementary Table S4). To nar-
row down the number of candidates, the CNOT1 IP was
repeated but complexes were eluted using the peptide used
to raise the CNOT1 antibody (Supplementary Figure S7I).
This resulted in a much longer list of CNOT1 binding pro-
teins (Supplementary Table S5) as expected since CNOT1
is part of several large multi-protein complexes. However,
combining the results of both experiments and selecting for
any proteins that were detected in all immunoprecipitations
but not in either of the IgG controls resulted in a list of
50 potential proteins that were in a complex with eIF4A2–
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/47/15/8224/5513320 by U
niversity of G
lasgow
 user on 10 M
arch 2020
Nucleic Acids Research, 2019, Vol. 47, No. 15 8233
CNOT1 (Table 1). Many of these proteins have previously
been identified as RNA binding proteins (36). Some have
also been identified as part of the CCR4–NOT complex
such as CNOT3, COPA, PABP1, RFC4 and TAB182 (13).
It is interesting to note that Lau et al. (13) also detected
an interaction between several of the CNOT subunits and
eIF4A. Although they identified this as eIF4A1, this may
have beenmisannotated due to the extremely high similarity
between eIF4A1 and eIF4A2, which makes it very difficult
to distinguish between them by MS analysis.
The interaction of several of the MS candidates was con-
firmed by immunoprecipitation followed by western blot-
ting. All potential candidates tested were confirmed to in-
teract with both CNOT1 and eIF4A2 (Supplementary Fig-
ure S8A) and to be present in fractions 30–32 after gel fil-
tration (Supplementary Figure S8B) with the exception of
the ribosomal proteins, RPL7a and RPL15, which showed
background binding to IgG (Supplementary Figure S8A).
The ribosomal proteins have therefore been excluded from
further analysis. To identify any proteins that were interact-
ing specifically with eIF4A2 we performed immunoprecipi-
tations for eIF4A1 and eIF4A2 using HeLa lysate (Supple-
mentary Figure S9A). Both antibodies precipitated compa-
rable levels of eIF4A1 and eIF4A2 respectively as shown by
the pan eIF4A antibody. This antibody has a similar affin-
ity for eIF4A1 and eIF4A2, detecting eIF4A1 slightly more
efficiently (eIF4A1/eIF4A2 = 1.5; Supplementary Figure
S9B). This established that many of the proteins were in-
teracting with both eIF4A1 and eIF4A2, as expected based
on the high similarity of eIF4A1 and eIF4A2 amino acid se-
quence. TAB182 was the only new protein identified in the
mass spectrometry experiments to precipitate with DDX6
and eIF4A2 but not eIF4A1 (Figure 5B, Supplementary
Figure S9A), suggesting a role in miRNAmediated transla-
tional repression. TAB182 (also known as tankyrase 1 bind-
ing protein, TNKS1BP1) plays a role inDNAdouble strand
break repair (37) and is involved in actin cytoskeleton rear-
rangement and cancer cell invasion (38). It has also been
identified as part of the CCR4–NOT complex but its func-
tion therein remains unknown (13).
To confirm the role of TAB182 as part of theCCR4–NOT
complex we knocked down TAB182 followed by transfec-
tion of the let-7 reporter constructs. The knockdown facil-
itated derepression in the let-7 reporter assay (Figure 5C,
Supplementary Figure S9C andD). These results confirmed
the involvement of TAB182 in miRNA mediated repres-
sion of translation. To investigate whether TAB182 had
any effect on CCR4–NOT complex composition we im-
munoprecipitated CNOT1 following TAB182 knockdown.
The interaction between CNOT1-CNOT7 and CNOT1–
DDX6 remained the same (Figure 5D and E). Surprisingly,
TAB182 knockdown increased eIF4A2 incorporation into
the CCR4–NOT complex (Figure 5D and E). These results
show that TAB182 has the ability to change CCR4–NOT
complex composition, determining which helicase is asso-
ciated with the CCR4–NOT complex.
eIF4A2 inhibits CNOT7 deadenylation activity
To date, our knowledge regarding the role of the DEAD-
box helicases in the CCR4–NOT complex is rather limited.
Figure 6. eIF4A2 inhibits CNOT7 deadenylation activity. (A) In vitro
deadenylation assays were performed with recombinant proteins and 5′-
Dy780-labelled RNA. Aliquots were taken after indicated time points and
resolved on denaturing TBE–urea gels. M = substrate + deadenylated
product marker. Representative gels are shown. (B) Bands were quantified
and the fraction of fully deadenylated product over time plotted as mean
± sd, n = 3 biological repeats.
In embryonic stem cells CNOT1 boundDDX6 is important
for translational repression rather than mRNA destabiliza-
tion (39) even though DDX6 bound mRNAs have slightly
shorter poly(A) tails compared to total mRNA of HEK293
cells (40). Translational repression can be achieved via inter-
action of DDX6 with 4E-T which interacts with the 5′end
of an mRNA (41–43).
To establish the role of eIF4A2 and DDX6 in the CCR4–
NOT complex we performed in vitro deadenylation assays.
CNOT7 alone was a very poor deadenylase (Figure 6A;
5,6,44,45) but CNOT7 activity was stimulated in the pres-
ence of the MA3 and MIF domains of CNOT1 (Figure 6A
and B). DDX6 stimulated CNOT7 deadenylation activity
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Table 1. Consolidated MS data. MS data from Supplementary Tables S4 and S5 were ranked on total spectra/molecular weight with the highest number
ranked 1 and combined
via CNOT1, however, eIF4A2 had a strong inhibitory ef-
fect on CNOT7 (Figure 6A and B). eIF4A1 has a similar
effect as eIF4A2 (Supplementary Figure S10A) and in vitro
experiments using recombinant proteins eIF4A1 shows that
it can interact with CNOT1 (Supplementary Figure S10B).
However, we do not observe eIF4A1 interacting strongly
with CNOT1 in vivo (Figure 2A) suggesting that in isolation
these proteins can interact but that they are not interacting
under physiological conditions. To further evaluate the abil-
ity of the helicases to interact specifically we conducted an
immunoprecipitation experiment using recombinant pro-
teins and found that a truncated version of eIF4G con-
taining the MIF and MA3 domains (eIF4G-MIF-MA3)
could interact with eIF4A1, eIF4A2 and DDX6, therefore,
no specificity was observed in vitro (Supplementary Figure
S10C). However, in the cell eIF4A1 is predominantly inter-
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Figure 7. eIF4A2 and DDX6 compete to inhibit/promote deadenylation.
(A) In vitro deadenylation assays were performed as in Figure 6A with in-
creasing amounts of eIF4A2 as indicated. Representative gels are shown.
(B) Bands were quantified and deadenylation speed was plotted as mean
± sd, n = 3 biological repeats.
acting with eIF4G and in this role it is involved in stimu-
lating translational efficiency rather than the regulation of
CNOT7 efficiency. To exclude the possibility that eIF4A2 is
binding to the RNA substrate and preventing access to the
poly(A) tail we repeated the deadenylation assay with an
eIF4A2 mutant that cannot bind RNA (eIF4A2DAAD; Sup-
plementary Figure S10D; 46). This mutant still repressed
deadenylation, therefore it is the interaction of eIF4A2 with
CNOT1 that is critical for inhibition of CNOT7 (Figure 6A
and B). Because eIF4A2 and DDX6 compete for binding
to CNOT1 this would predict that including both helicases
in the deadenylation assay has a competitive effect. Indeed,
when increasing amounts of eIF4A2 were added to a dead-
enylation assay containing CNOT1, CNOT7 and DDX6
the deadenylation rate decreased with increasing amounts
of eIF4A2 (Figure 7A and B).
These results implied that mRNAs bound to the
CNOT1–eIF4A2 complex should have a longer poly(A)
tail than mRNAs that are bound to the CNOT1–DDX6
complex. To test this hypothesis, we performed poly(A)
tests (PAT) on eIF4A2 and DDX6 bound mRNAs (Fig-
ure 8A). Endogenous eIF4A2 and DDX6 immunoprecip-
itations identified several mRNAs that have the ability to
bind both eIF4A2 and DDX6 (unpublished data Wilczyn-
ska et al.). Endogenous RNA immunoprecipitations were
performed for eIF4A2 and DDX6 and the poly(A) tail
length of associated mRNAs was determined by PAT as-
say. Target mRNAs for the PAT assay were selected based
on high abundance and their ability to bind both eIF4A2
and DDX6 efficiently. eIF4A2 bound mRNAs had vary-
ing poly(A) tail lengths whilst DDX6 bound mRNAs had
a very short or no poly(A) tail (Figure 8A, Supplementary
Figure S11A). The variability in poly(A) tail length amongst
the eIF4A2 bound mRNAs was a reflection of the aver-
age poly(A) tail length of total mRNA in the cell (Sup-
plementary Figure S11B). mRNAs that bind exclusively
to eIF4A2 had a varied poly(A) tail length, similar to the
mRNAs that could bind both eIF4A2 and DDX6, show-
ing again that eIF4A2 inhibited deadenylation (Supplemen-
tary Figure S12). To determine whether the lack of dead-
enylation activity of the eIF4A2–CNOT1–CNOT7 com-
plex was caused by eIF4A2 interfering with the CNOT1–
CNOT7 interaction we employed eIF4A2 immunoprecip-
itations which showed a clear interaction of eIF4A2 with
CNOT7 (Figure 8B), as demonstrated before (15). We then
used recombinant protein immunoprecipitations using dif-
ferent combinations of CNOT1, CNOT7 and eIF4A2 or
DDX6 to analyse if these proteins affected each other’s
affinity for CNOT1 (Supplementary Figure S11C). These
CNOT1 immunoprecipitations showed that eIF4A2 and
DDX6 do not inhibit CNOT7 binding to CNOT1 and that
CNOT7 does not affect the binding of eIF4A2 or DDX6 to
CNOT1. Moreover, knockdown of eIF4A2 in HeLa cells
followed by immunoprecipitation of CNOT1 showed that
the presence or absence of eIF4A2 in the CCR4–NOT com-
plex does not affect CNOT7 binding to CNOT1 (Figure
8C). The same was observed when eIF4A2 incorporation
in the complex was increased following TAB182 knock-
down (Figure 5D and E). Together, these data revealed that
the repression of deadenylation activity of the eIF4A2–
CNOT1–CNOT7 complex was not a consequence of dimin-
ished CNOT7 binding suggesting that eIF4A2 affects either
CNOT7 deadenylation function or the ability of CNOT7 to
access the poly(A) tail.
Together, these data show that eIF4A2 and DDX6 have
distinct functions when interacting with the CCR4–NOT
complex resulting in a different outcome for the targeted
mRNA as described in the model shown in Figure 9. When
the eIF4A2–CNOT1 complex is recruited to an mRNA
it remains polyadenylated. In contrast, when the DDX6–
CNOT1 complex gets recruited it results in deadenyla-
tion of the mRNA. The exact composition of the CCR4–
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Figure 8. eIF4A2 bound mRNAs have a longer poly(A) tail than DDX6 bound mRNAs. (A) HEK293 RNA was immunoprecipitated with the indicated
antibodies and analysed by poly(A) test (PAT) for six different targets. Deadenylated RNA was generated by incubating total RNA with RNaseH and
oligo(dT). A0 indicates deadenylated PCR product. *Indicates a non-specific PCR product. (B) HEK293 cells were lysed and lysates were used for im-
munoprecipitation and analysed by western blotting. Representative blots are shown. *Indicates a non-specific reaction with the light chain. (C) HeLa
cells were treated with siRNAs as indicated. Cells were lysed after 72 h and the resulting lysates were immunoprecipitated. Resulting complexes were eluted
using CNOT1 peptide and analysed by western blotting. Representative blots are shown. GAPDH is a loading control.
Figure 9. eIF4A2 inhibits CNOT7 deadenylation activity. An actively translated mRNA is bound by several initiation factors, including eIF4A1 (top).
When the CCR4–NOT complex is recruited the mRNA is translationally repressed. If the CCR4–NOT complex includes eIF4A2 the poly(A) tail remains
intact (bottom left). If the CCR4–NOT complex includes DDX6 instead the mRNA can be deadenylated (bottom right). TAB182 decreases eIF4A2
incorporation into the CCR4–NOT complex and therefore could affect the poly(A) tail length of the mRNA.
NOT complex varies dependent on the circumstances. Each
CCR4–NOT complex contains two deadenylases: CNOT7
or CNOT8 binds directly to the MIF domain of CNOT1
and CNOT6 or CNOT6L binds via CNOT7/8 resulting in
four possible combinations of deadenylases in the complex
(13). These deadenylases cooperate with PABP to determine
deadenylation efficiency (5,6). Whilst CNOT7/8 removes
the poly(A) tail which is not bound by PABP, CNOT6/6L
is responsible for displacing PABP resulting in a cycling
mechanism of poly(A) removal. Reduced PABP binding of
miRNA targeted mRNAs renders them particularly vul-
nerable to CNOT7/8 deadenylation (5). Our data showed
that eIF4A2 and DDX6 bind CNOT1 directly via theMA3
and MIF domains of CNOT1. Moreover, DDX6 in com-
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plex with CNOT1 stimulates CNOT7 deadenylation activ-
ity whilst eIF4A2 in complex with CNOT1 inhibits CNOT7
activity resulting inmarkedly different outcomes for the tar-
geted mRNA (Figure 9). Our data suggest that of the mR-
NAs that can bind eIF4A2 andDDX6, TAB182 availability
could determinewhich helicasewill be incorporated into the
CCR4–NOT complex. The fate of each mRNA is depen-
dent on the choice of recruitment of eIF4A2 or DDX6 to
the CCR4–NOT complex and the subsequent effect on the
deadenylation of the mRNA.
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